PPARs are mediators of anti-cancer properties of superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with conjugated linoleic acid

Chem Biol Interact. 2018 Aug 25:292:9-14. doi: 10.1016/j.cbi.2018.07.003. Epub 2018 Jul 3.

Abstract

Breast cancer chemotherapy can cause side effects due to nonspecific drug delivery, low solubility and fast metabolism of drugs used in conventional therapy. Moreover, the therapeutic effect of the drugs is often reduced by the strengthening of chemoresistance, which occurs via a variety of mechanisms. Different strategies have been developed to reduce multidrug resistance (MDR)-associated gene expressions including the use of surfactants and polymers. In this study superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with conjugated linoleic acid (CLA) reduced the number and viability of cells in comparison with both untreated cells or cells treated with SPIONs alone. This cytostatic effect correlated with the increase of peroxisome proliferator-activated receptors γ (PPARγ). The necrotic cell death induced, as a consequence, an inflammatory process, as evidenced by the decrease of the anti-inflammatory PPARα and increase of pro-inflammatory TNFα and IL-1β. PPARs were examined because CLA is one of their natural ligands. The antitumor effect observed was accompanied by a down-regulation of p-glycoprotein (P-gp), which was the first important discovered efflux transporter belonging to MDR, and of ALDH3A1, an enzyme able to metabolize some drugs, reducing their effects. The down-regulation of P-gp correlated with the increase of cytokines. The ALDH3A1 decrease correlated with the increase of PPARγ. Based on these results, PPARs are molecular mediators of anti-cancer effect of SPIONs functionalized with CLA, being changes in these nuclear receptors correlated with induction of cytotoxicity and inflammation, and decreased ability of cancer cells in blocking anti-cancer drug effect.

Keywords: ALDH3A1; Breast cancer 4T1 cells; CLA; P-gp; PPARs; SPIONs.

MeSH terms

  • Anilides / pharmacology
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Apoptosis / drug effects
  • Breast Neoplasms
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival
  • Female
  • Interleukin-1beta / metabolism
  • Linoleic Acids, Conjugated / chemistry*
  • Linoleic Acids, Conjugated / therapeutic use
  • Magnetite Nanoparticles / chemistry*
  • Magnetite Nanoparticles / therapeutic use
  • Mice
  • Peroxisome Proliferator-Activated Receptors / pharmacology*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • 2-chloro-5-nitrobenzanilide
  • Anilides
  • Antineoplastic Agents
  • Interleukin-1beta
  • Linoleic Acids, Conjugated
  • Magnetite Nanoparticles
  • Peroxisome Proliferator-Activated Receptors
  • Tumor Necrosis Factor-alpha